Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsTreatment day guide
Spravato treatment is planned around safety, monitoring, and reliable follow-up. The visit includes preparation, supervised nasal spray administration, observation after dosing, and a clear plan for leaving the clinic safely.
Multi-location Spravato access across NYC and Long Island, with care-manager support, Medicaid access, and clinic options that account for repeated monitored visits.
Before a treatment day is scheduled, Nao Medical reviews clinical fit, insurance status, current medications, blood pressure considerations, and logistics. Patients should plan enough time for the visit and arrange transportation home, because driving after treatment is not allowed.
Spravato is self-administered as a nasal spray under direct healthcare-provider supervision. The care team monitors you after dosing and checks whether you are clinically stable before you leave. Monitoring may include symptom checks, side-effect review, blood pressure review, and observation for sedation, dissociation, or other concerns.
Patients should not drive, operate machinery, or make high-risk decisions until the next day after restful sleep. Your care team will review your next appointment, side effects to report, and how to reach the clinic with questions after your visit.
Repeated monitored visits are easier when the location fits your commute.
Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsBronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for patients who want local Spravato care without leaving the borough.
View location detailsLong Island
232 W Old Country Rd, Hicksville, NY 11801
A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.
View location detailsQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.
View location detailsQueens
30-07 36th Ave, Astoria, NY 11106
A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.
View location detailsLong Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for patients who want strong benefits support and reliable treatment coordination.
View location detailsManhattan
259 1st Ave, New York, NY 10003
A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.
View location detailsBrooklyn
308 Graham Ave, Brooklyn, NY 11211
The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.
View location detailsPatients are monitored for at least two hours after dosing. Plan extra time for check-in, preparation, and discharge review.
No. Patients need a safe ride home after each Spravato treatment day.
No. Spravato is administered only in a certified healthcare setting and is not dispensed for home use.
Yes. The care team monitors for side effects during the post-dose observation period and reviews what to watch for after you leave.